Mar. 2 at 1:41 PM
Zoetis Inc. agreed to acquire the animal genomics business of Neogen Corporation for
$160 million in cash, expanding its capabilities in precision animal health.
The acquisition will provide Zoetis with advanced genetic testing technologies and data analytics tools designed to improve the prediction of health outcomes and enable more tailored treatment and breeding decisions for livestock and companion animals. The genomics unit serves customers in more than 120 countries and operates five laboratories across the U.S., Brazil, Australia, China, and the U.K., along with an office in Canada.
Zoetis said the transaction is expected to close in the second half of calendar 2026, subject to customary conditions. The company’s shares have risen about 4.2% in 2025.
$ZTS $NEOG